Allergan rose $6.21 or 4.0 percent, to $161.82. Baxter International Inc. fell$. 08 or. 1 percent, to $75.13. Boston Scientific Corp. fell$. 05 or. 4 percent, to $12.59.» Read More
Allergan fell $3.20 or 2.0 percent, to $153.63. Baxter International Inc. rose$. 67 or. 9 percent, to $74.57. Boston Scientific Corp. rose$. 03 or. 2 percent, to $12.36.
Allergan fell $1.69 or 1.1 percent, to $155.14. Baxter International Inc. rose$. 51 or. 7 percent, to $74.41. Boston Scientific Corp. fell$. 07 or. 6 percent, to $12.26.
U.S. biotech firm Celladon hopes that its Mydicar treatment can help patients like Lee Adams who have advanced heart failure and rely on so called Left Ventricular Assist Devices to keep them alive until a donor heart becomes available.
Allergan rose $4.91 or 3.2 percent, to $156.83. Johnson& Johnson rose $1.15 or 1.2 percent, to $101.08. Medtronic rose $1.15 or 1.9 percent, to $62.15.
Allergan rose $3.93 or 2.6 percent, to $155.85. Baxter International Inc. rose$. 10 or. 1 percent, to $73.87. Boston Scientific Corp. fell$. 11 or. 9 percent, to $12.16.
Allergan rose $2.31 or 1.5 percent, to $154.23. Baxter International Inc. fell$. 38 or. 5 percent, to $73.39. Boston Scientific Corp. fell$. 16 or 1.3 percent, to $12.10.
SAN FRANCISCO, Aug 6- Practice Fusion, provider of a free electronic health record service for doctors, bought app developer Ringadoc on Wednesday as it moves into a new market: telemedicine. Research firm IHS forecast that the U.S. market will grow to $1.9 billion in 2018, from $240 million in 2013..
Aug 5- Cerner Corp, a U.S. provider of healthcare information technology services, said it will buy the assets of Siemens AG's healthcare division for $1.3 billion. The acquisition is expected to close in the first quarter of 2015 and will be financed with cash on hand, Cerner said.
Aug 4- Symmetry Medical Inc said it would sell its orthopedic device component business to privately held Tecomet Inc for $450 million. Symmetry Medical will transfer ownership of its remaining surgical instruments business to its shareholders as a new company.
Aug 4- Medical device maker Symmetry Medical Inc said it would sell its orthopedic device components business to privately held Tecomet Inc for $450 million. Symmetry Medical will transfer ownership of its remaining surgical instruments business to its shareholders as a new company.
Lawrence Livermore is reaching out to private industry amid a race for talent and ideas to solve pressing issues including national security.
July 30- Johnson& Johnson said on Wednesday it plans to ask doctors to return its power morcellators, a controversial surgical device that may inadvertently spread cancer in women being treated for uterine growths called fibroids. The FDA had advised doctors not to use the devices pending further review.
July 30- Hospira Inc, a pharmaceutical and medical device maker, posted a better-than-expected quarterly profit on higher sales of specialty injectable drugs, and raised its full-year outlook.
The Senate Judiciary Committee's nine-member antitrust panel will meet on Wednesday to consider the decisions by Alcon, owned by Novartis AG; Bausch& Lomb, owned by Valeant Pharmaceuticals; and Johnson& Johnson to put in place minimum sale prices for some of their products.
The Senate Judiciary Committee's nine-member antitrust panel will meet on Wednesday to consider the decisions by Alcon, owned by Novartis AG; Bausch+ Lomb, owned by Valeant Pharmaceuticals; and Johnson& Johnson to put in place minimum sale prices for some of their products.
CRE, one of the worst of the superbugs, is spreading in some hospitals, and there's worry that cases are under-reported.
July 24- Boston Scientific Corp, which makes medical equipment, on Thursday reported a slightly higher-than-expected quarterly profit as improvements in its heart device business helped drive revenue up 4 percent.
July 17- Medical device and drug maker Baxter International Inc reported higher-than-expected quarterly adjusted earnings, driven primarily by a surge in sales of the dialysis products it gained from its acquisition of Gambro AB last year.
In the most recent such deal in the medical device sector, Medtronic Inc last month agreed to buy Covidien for $43 billion. The move will allow Medtronic to re-domicile to Ireland to take advantage of low corporate tax rates and to access cash overseas without having to pay high repatriation costs.
July 11- Medical device maker Covidien Plc said it recorded a pre-tax charge of about $180 million for the third quarter, related to litigation against some manufacturers of pelvic mesh products. Covidien said it was indemnifying the manufacturer on certain claims.